Funding Supports Advancement of KAN-101 for Celiac Disease into Phase 2 Clinical Development Pfizer Representatives Join Scientific Advisory Board and Board of Directors Anokion SA, a clinical-stage
Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors Funding will support next stage of clinical and corporate development
CHMP also recommends XELJANZ (tofacitinib) approval for the treatment of adults with active ankylosing spondylitis Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency's
Pfizer Inc.: XELJANZ (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Theratechnologies Announces Two Strategic Hires to Support its Commercial and Pipeline Assets globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.